Transplantation and cancer

Abstract

The incidence of cancer is increased in transplant recipients; this increase is due to the immunosuppressive treatment but this treatment must be maintained to prevent rejection. Skin cancer, posttransplant lymphoproliferative disorders (PDLT) and gastroenteric tumours are the most frequently observed malignancies. In this population, these cancers have a more aggressive course than in the general population, making indispensable their early detection and management, including the reduction of immunosuppressive treatment.